Industry · SIC 2834
Pharmaceutical Preparations
1696 tracked issuers filing with the SEC under this industry classification.
Issuers
1696
Recent filings
40
SIC code
2834
Industry overview
Pharmaceutical Preparations
Pharmaceutical Preparations (SIC 2834) covers companies formulating, manufacturing, and marketing prescription drugs, over-the-counter remedies, vaccines, biologics, and specialty therapies for hospitals, clinics, pharmacies, PBMs, and increasingly direct-to-consumer channels. Customers span health systems, insurers, physicians, and patients managing chronic and acute conditions. The sector operates under FDA and EMA approvals, GMP compliance, pharmacovigilance duties, patent cliffs, pricing scrutiny, and evolving rules on digital promotion and AI-driven clinical decision support. Key risks include clinical trial setbacks, supply chain fragility for active ingredients, reimbursement pressure, and heightened cybersecurity expectations around patient data. In 2024-2025, firms are accelerating mRNA platforms, cell and gene therapies, GLP-1 and metabolic drugs, antibody-drug conjugates, and digital companions, while optimizing portfolios through licensing and M&A to offset patent expirations. For timely disclosures, pipeline updates, and pricing actions, view SEC filings on Earnings Feed.
Source: Earnings Feed research · Nov 23, 2025
Latest filings
- S-1GTBPGT Biopharma, Inc.957.0 KBSEC(opens sec.gov)
- SCHEDULE 13G/AVNDAVanda Pharmaceuticals Inc.20.0 KBSEC(opens sec.gov)
- 6-KLKFTLakefront Biotherapeutics NV54.6 KBSEC(opens sec.gov)
- 8-KSBFMSunshine Biopharma Inc.879.4 KBSEC(opens sec.gov)
- 8-KSERSerina Therapeutics, Inc.927.1 KBSEC(opens sec.gov)
- 8-KQUCYQuantum Cyber N.V.606.4 KBSEC(opens sec.gov)
- 8-KVTGNVistagen Therapeutics, Inc.395.6 KBSEC(opens sec.gov)
- 8-KARTLARTELO BIOSCIENCES, INC.143.8 KBSEC(opens sec.gov)
- 8-KMBRXMoleculin Biotech, Inc.342.7 KBSEC(opens sec.gov)
- S-1/ABirchBioMed Inc.7.6 MBSEC(opens sec.gov)
- SCHEDULE 13D/ASYRESpyre Therapeutics, Inc.19.4 KBSEC(opens sec.gov)
- 6-KSXTCChina SXT Pharmaceuticals, Inc.671.0 KBSEC(opens sec.gov)
- 8-KIBOIMPACT BIOMEDICAL INC.2.4 MBSEC(opens sec.gov)
- 8-KHEPAHepion Pharmaceuticals, Inc.973.2 KBSEC(opens sec.gov)
- SCHEDULE 13GQTTBQ32 Bio Inc.29.3 KBSEC(opens sec.gov)
- 8-KTCRTAlaunos Therapeutics, Inc.188.6 KBSEC(opens sec.gov)
- SCHEDULE 13G/ATENXTENAX THERAPEUTICS, INC.77.2 KBSEC(opens sec.gov)
- 144PTCTPTC THERAPEUTICS, INC.6.3 KBSEC(opens sec.gov)
- 8-KCTTHSEC(opens sec.gov)
- S-1Aspen Neuroscience, Inc.23.8 MBSEC(opens sec.gov)
- 8-KCRVOCervoMed Inc.164.6 KBSEC(opens sec.gov)
- SCHEDULE 13G/ADERMJourney Medical Corp7.4 KBSEC(opens sec.gov)
- SCHEDULE 13G/APYXSPyxis Oncology, Inc.21.4 KBSEC(opens sec.gov)
- 8-KLNAILunai Bioworks Inc.193.3 KBSEC(opens sec.gov)
- 8-KVOGXVogenx, Inc.216.0 KBSEC(opens sec.gov)
- 144ZYMEZymeworks Inc.4.7 KBSEC(opens sec.gov)
- 8-KJAZZJazz Pharmaceuticals plc145.6 KBSEC(opens sec.gov)
- 6-KEPRXSEC(opens sec.gov)
- 8-KATOSATOSSA THERAPEUTICS, INC.566.2 KBSEC(opens sec.gov)
- 6-KGHRSGH Research PLC9.6 KBSEC(opens sec.gov)
- 144URGNUroGen Pharma Ltd.4.4 KBSEC(opens sec.gov)
- 8-K/ARNAAtrium Therapeutics, Inc.146.3 KBSEC(opens sec.gov)
- S-1/ACTYCITY THERAPEUTICS, INC.8.1 MBSEC(opens sec.gov)
- 6-KATHEALTERITY THERAPEUTICS LTD29.4 KBSEC(opens sec.gov)
- 3LLYELI LILLY & Co4.6 KBSEC(opens sec.gov)
- SCHEDULE 13D/AGOSSGossamer Bio, Inc.54.8 KBSEC(opens sec.gov)
- SCHEDULE 13D/AAVBPArriVent BioPharma, Inc.33.8 KBSEC(opens sec.gov)
- SCHEDULE 13G/AVTVTvTv Therapeutics Inc.19.6 KBSEC(opens sec.gov)
- SCHEDULE 13G/ACOLLSEC(opens sec.gov)
- 8-KFBLGFibroBiologics, Inc.696.4 KBSEC(opens sec.gov)
Featured issuers
- 2seventy bio, Inc.CIK 0001860782
- 3 DIMENSIONAL PHARMACEUTICALS INCCIK 0000914201
- 3SBio Inc.CIK 0001383790
- 4D Pharma PLCCIK 0001830162
- 60 DEGREES PHARMACEUTICALS, INC.CIK 0001946563SXTP
- 89bio, Inc.CIK 0001785173ETNB
- 9 METERS BIOPHARMA, INC.CIK 0001551986
- Aardvark Therapeutics, Inc.CIK 0001774857AARD
- ABBOTT BIOTHERAPEUTICS CORPCIK 0001441848
- ABBOTT LABORATORIESCIK 0000001800ABT
- AbbVie Inc.CIK 0001551152ABBV
- AbCellera Biologics Inc.CIK 0001703057ABCL
Classification
- SIC code
- 2834
- Total issuers
- 1696
- Recent filings
- 40